Expression of cell proliferation and apoptosis biomarkers in pterygia and normal conjunctiva

Molecular Vision

Volumn 17, Issue , 2011, Pages 1687-1693

  Liang, Kun ^a   Jiang, Zhengxuan ^a   Ding, Bi Qing ^a   Cheng, Ping ^a   Huang, Da Ke ^a   Tao, Li ming ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CYCLINE; KI 67 ANTIGEN; MUTANT PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; BARE SCLERA PROCEDURE; CELL PROLIFERATION; CHINESE; CLINICAL ARTICLE; CONJUNCTIVA; CONJUNCTIVA EPITHELIUM; CONTROLLED STUDY; EPITHELIUM CELL; EYE SURGERY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PTERYGIUM; SURGICAL TECHNIQUE;

ADULT; AGED; APOPTOSIS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CELL PROLIFERATION; CONJUNCTIVA; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KI-67 ANTIGEN; MALE; MIDDLE AGED; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-BCL-2; PTERYGIUM; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 79960012096     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Di Girolamo N, Chui J, Coroneo MT, Wakefield D. Pathogenesis of pterygia: role of cytokines, growth factors, and matrix metalloproteinases. Prog Retin Eye Res 2004; 23:195-228. [PMID: 15094131]
2. Sekundo W, Droutsas K, Cursiefen C. Operative techniques for surgical treatment of primary and recurrent pterygia. Ophthalmologe 2010; 107:525-528. [PMID: 20401504]
3. Golu T, Mogoanta L, Streba CT, Pirici DN, Malaescu D, Mateescu GO, Mutiu G. Pterygium: histological and immunohistochemical aspects. Rom J Morphol Embryol 2011; 52:153-158. [PMID: 21424047]
4. Kase S, Osaki M, Jin XH, Ohgami K, Yoshida K, Saito W, Takahashi S, Nakanishi K, Ito H, Ohno S. Increased expression of erythropoietin receptor in human pterygial tissues. Int J Mol Med 2007; 20:699-702. [PMID: 17912463]
5. Kaimbo K. Surgical treatment of pterygium: 24 cases of excision. J Fr Ophtalmol 1988; 11:335-338. [PMID: 3171100]
6. Chowers I, Pe'er J, Zamir E, Livni N, Ilsar M, Frucht-Pery J. Proliferative activity and p53 expression in primary and recurrent pterygia. Ophthalmology 2001; 108:985-988. [PMID: 11320032]
7. Kase S, Takahashi S, Sato I, Nakanishi K, Yoshida K, Ohno S. Expression of p27(KIP1) and cyclin D1, and cell proliferation in human pterygium. Br J Ophthalmol 2007; 91:958-961. [PMID: 17179165]
8. Tan DT, Liu YP, Sun L. Flow cytometry measurements of DNA content in primary and recurrent pterygia. Invest Ophthalmol Vis Sci 2000; 41:1684-1686. [PMID: 10845586]
9. Karukonda SR, Thompson HW, Beuerman RW, Lam DS, Wilson R, Chew SJ, Steinemann TL. Cell cycle kinetics in pterygium at three latitudes. Br J Ophthalmol 1995; 79:313-317. [PMID: 7742273]
10. Tan DT, Tang WY, Liu YP, Goh HS, Smith DR. Apoptosis and apoptosis related gene expression in normal conjunctiva and pterygium. Br J Ophthalmol 2000; 84:212-216. [PMID: 10655200]
11. Hsu SM, Raine L, Fanger H. The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. Am J Clin Pathol 1981; 75:816-821. [PMID: 6167159]
12. Khalfaoui T, Mkannez G, Colin D, Imen A, Zbiba W, Errais K, Anane R, Beltaief O, Zhioua R, Ben Hamida J, Lizard G, Ouertani-Meddeb A. Immunohistochemical analysis of vascular endothelial growth factor (VEGF) and p53 expression in pterygium from Tunisian patients. Pathol Biol (Paris) 2011; 59:137-141. [PMID: 19481369]
13. Garfias Y, Bautista-De Lucio VM, Garcia C, Nava A, Villalvazo L, Jimenez-Martinez MC. Study of the expression of CD30 in pterygia compared to healthy conjunctivas. Mol Vis 2009; 15:2068-2073. [PMID: 19862340]
14. Ando R, Kase S, Ohashi T, Dong Z, Fukuhara J, Kanda A, Murata M, Noda K, Kitaichi N, Ishida S. Tissue factor expression in human pterygium. Mol Vis 2011; 17:63-69. [PMID: 21245964]
15. Sakoonwatanyoo P, Tan DT, Smith DR. Expression of p63 in pterygium and normal conjunctiva. Cornea 2004; 23:67-70. [PMID: 14701960]
16. Bai H, Teng Y, Wong L, Jhanji V, Pang CP, Yam GH. Proliferative and migratory aptitude in pterygium. Histochem Cell Biol 2010; 134:527-535. [PMID: 20938674]
17. Prives C, Gottifredi V. The p21 and PCNA partnership: a new twist for an old plot. Cell Cycle 2008; 7:3840-3846. [PMID: 19066467]
18. Lee KY, Myung K. PCNA modifications for regulation of postreplication repair pathways. Mol Cells 2008; 26:5-11. [PMID: 18525240]
19. Ueda Y, Kanazawa S, Kitaoka T, Dake Y, Ohira A, Ouertani AM, Amemiya T. Immunohistochemical study of p53, p21 and PCNA in pterygium. Acta Histochem 2001; 103:159-165. [PMID: 11368097]
20. Oren M, Rotter V. Mutant p53 gain-of-function in cancer. Cold Spring Harb Perspect Biol 2010; 2:a001107. [PMID: 20182618]
21. Tsai YY, Cheng YW, Lee H, Tsai FJ, Tseng SH, Chang KC. P53 gene mutation spectrum and the relationship between gene mutation and protein levels in pterygium. Mol Vis 2005; 11:50-55. [PMID: 15682042]
22. Weinstein O, Rosenthal G, Zirkin H, Monos T, Lifshitz T, Argov S. Overexpression of p53 tumor suppressor gene in pterygia. Eye (Lond) 2002; 16:619-621. [PMID: 12194078]
23. Reszec J, Sulkowska M, Koda M, Kanczuga-Koda L, Sulkowski S. Expression of cell proliferation and apoptosis markers in papillomas and cancers of conjunctiva and eyelid. Ann N Y Acad Sci 2004; 1030:419-426. [PMID: 15659825]
24. Pradelli LA, Beneteau M, Ricci JE. Mitochondrial control of caspase-dependent and -independent cell death. Cell Mol Life Sci 2010; 67:1589-1597. [PMID: 20151314]